PE0105
/ Shanghai Yunyi Health Technology
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 15, 2023
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1/2 | N=120 | Recruiting | Sponsor: Shanghai HyaMab Biotech Co.,Ltd. | Not yet recruiting ➔ Recruiting | Initiation date: May 2023 ➔ Sep 2023
Enrollment open • Metastases • Trial initiation date • Gastrointestinal Cancer • Oncology • Solid Tumor
September 07, 2023
A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1/2 | N=120 | Not yet recruiting | Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
New P1/2 trial • Head and Neck Cancer • Oncology • Ovarian Cancer • Renal Cell Carcinoma • Solid Tumor
April 06, 2023
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1/2 | N=120 | Not yet recruiting | Sponsor: Shanghai HyaMab Biotech Co.,Ltd.
Metastases • New P1/2 trial • Gastrointestinal Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1